Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

VYNE Therapeutics (VYNE) Other Gross PP&E Adjustments (2016 - 2025)

VYNE Therapeutics' Other Gross PP&E Adjustments history spans 9 years, with the latest figure at $117000.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 387.5% year-over-year to $117000.0; the TTM value through Dec 2025 reached $117000.0, up 387.5%, while the annual FY2025 figure was $117000.0, 387.5% up from the prior year.
  • Other Gross PP&E Adjustments reached $117000.0 in Q4 2025 per VYNE's latest filing, up from $85000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $905000.0 in Q4 2021 to a low of -$1.4 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 4 years is -$261833.3, with a median of -$136500.0 recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: increased 18.25% in 2021, then surged 387.5% in 2025.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at $905000.0 in 2021, then crashed by 122.87% to -$207000.0 in 2023, then surged by 111.59% to $24000.0 in 2024, then soared by 387.5% to $117000.0 in 2025.
  • Per Business Quant, the three most recent readings for VYNE's Other Gross PP&E Adjustments are $117000.0 (Q4 2025), $85000.0 (Q2 2025), and $55000.0 (Q1 2025).